Arcturus Therapeutics Holdings IncArcturus Therapeutics Holdings Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This Sustainability score for Arcturus Therapeutics Holdings Inc represents the company's transparency towards the United Nations SDGs. The webpage contains a free Sustainability analysis for Arcturus Therapeutics Holdings Inc. This assessment of Arcturus Therapeutics Holdings Inc was assembled by All Street Sevva using proprietary machine learning.

Arcturus Therapeutics Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.3; made up of an environmental score of 6.0, social score of 4.8 and governance score of 8.0.

SDG Transparency Score for Arcturus Therapeutics Holdings Inc 
Low
0 - 3

6.3

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Arcturus Therapeutics Holdings Inc 
6.0

Environmental

4.8

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
402United Laboratories International Holdings Ltd
6.4
High
402Zenabis Global Inc
6.4
High
427Arcturus Therapeutics Holdings Inc
6.3
High
427Calliditas Therapeutics AB
6.3
High
427Carna Biosciences Inc
6.3
High
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Arcturus Therapeutics Holdings Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc offer flexible work?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose water use targets?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Arcturus Therapeutics Holdings Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Arcturus Therapeutics Holdings Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Arcturus Therapeutics Holdings Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose its waste policy?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose energy use targets?

LockedSign up for free to unlock

Does Arcturus Therapeutics Holdings Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Arcturus Therapeutics Holdings Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Arcturus Therapeutics Holdings Inc
These potential risks are based on the size, segment and geographies of the company.

Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lung disease caused by mutations in cystic fibrosis transmembrane conductance regulator (CFTR) gene, as well as vaccine programs include LUNAR-COV19 and LUNAR-FLU. It has collaboration partnerships with Vinbiocare Biotechnology Joint Stock Company for the manufacture of COVID-19 vaccines; Janssen Pharmaceuticals, Inc. to develop nucleic acid-based therapeutic candidates for the treatment of hepatitis B virus; Ultragenyx Pharmaceutical, Inc. to develop mRNA therapeutic candidates for rare disease targets; CureVac AG to develop mRNA therapeutic and vaccine candidates for various indications; Singapore Economic Development Board and Duke-NUS Medical School to develop LUNAR-COV19 vaccine; and Millennium Pharmaceuticals, Inc. to discover siRNA medicines for the treatment of non-alcoholic steatohepatitis. The company was founded in 2013 and is headquartered in San Diego, California.

Sorry!

Failed to process!